Dolphin Capital AG
Dolphin Capital AG plans acquisition of BIOCEN Distribution GmbH
Dolphin Capital AG / Strategic Company Decision/Acquisition Corporate news transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Berlin/Munich, 02/07/2007 ––Dolphin Capital AG, a holding company primarily specializing in the functional food & beverage segment, plans to take over BIOCEN Distribution GmbH, which belongs to the BIOCEN group of companies. BIOCEN GmbH’s stockholders have already approved of the transaction and in return will join Dolphin Capital AG as major shareholders. BIOCEN Distribution GmbH at the same time will obtain an extensive license, granting them the right to sell and distribute the products of BIOCEN Laboratories This license will replace the previous marketing agreement. A valuation report of BIOCEN GmbH – equipped with this license - is commissioned and will serve as the basis for the exact modalities of the takeover. At the moment the evaluation is reflected in the value of approx. 30 Million EURO. Presently Dolphin Capital AG’s upcoming shareholders’ meeting is being prepared. All further details concerning the takeover will be announced in the invitation to this shareholders’ meeting. Information regarding the product range as well as the respective companies can be found at www.BIOCEN.com and www.DolphinCapital.de. Dolphin Capital AG Einstein Palais Friedrichstrasse 171 10117 Berlin Germany Telefon +49 (0)30 30 366-5096 Telefax +49 (0)30 30 366-5097 www.DolphinCapital.de info@DolphinCapital.de DGAP 07.02.2007 ----------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden